Neuberger Berman Group LLC boosted its position in shares of HCP, Inc. (NYSE:HCP) by 10.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 64,646 shares of the real estate investment trust’s stock after purchasing an additional 6,171 shares during the quarter. Neuberger Berman Group LLC’s holdings in HCP were worth $1,701,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of HCP. Mount Yale Investment Advisors LLC purchased a new stake in HCP during the second quarter worth $104,000. Peoples Financial Services CORP. boosted its position in HCP by 87.7% during the third quarter. Peoples Financial Services CORP. now owns 6,100 shares of the real estate investment trust’s stock worth $161,000 after purchasing an additional 2,850 shares in the last quarter. Wetherby Asset Management Inc. purchased a new stake in HCP during the third quarter worth $200,000. Lourd Capital LLC purchased a new stake in HCP during the third quarter worth $211,000. Finally, First Hawaiian Bank purchased a new stake in HCP during the third quarter worth $215,000. Institutional investors own 88.83% of the company’s stock.
HCP stock opened at $28.61 on Wednesday. The firm has a market capitalization of $13.30 billion, a P/E ratio of 14.67, a price-to-earnings-growth ratio of 5.26 and a beta of 0.28. HCP, Inc. has a 52 week low of $21.48 and a 52 week high of $30.26. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 1.21.
HCP (NYSE:HCP) last announced its quarterly earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.11 by $0.10. The company had revenue of $456.00 million during the quarter, compared to analyst estimates of $456.59 million. HCP had a return on equity of 3.06% and a net margin of 9.16%. The firm’s revenue was up .4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.48 earnings per share. Research analysts predict that HCP, Inc. will post 1.82 EPS for the current year.
In other HCP news, COO Thomas Klaritch sold 82,532 shares of the company’s stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total transaction of $2,435,519.32. Following the completion of the sale, the chief operating officer now directly owns 256,280 shares in the company, valued at $7,562,822.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.14% of the company’s stock.
HCP has been the topic of several recent research reports. JPMorgan Chase & Co. downgraded HCP from an “overweight” rating to a “neutral” rating in a research report on Friday, October 5th. Cantor Fitzgerald upgraded HCP from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $28.00 to $29.00 in a research report on Thursday, September 27th. Royal Bank of Canada upgraded HCP from a “sector perform” rating to an “outperform” rating in a research report on Friday, November 2nd. ValuEngine upgraded HCP from a “hold” rating to a “buy” rating in a research report on Monday, November 12th. Finally, Bank of America upped their price objective on HCP from $27.50 to $28.00 and gave the company a “buy” rating in a research report on Monday, September 17th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $26.96.
ILLEGAL ACTIVITY WARNING: This news story was originally published by Stock Observer and is owned by of Stock Observer. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.thestockobserver.com/2019/01/09/hcp-inc-hcp-shares-bought-by-neuberger-berman-group-llc.html.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Further Reading: What is a Derivative?
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.